Ironwood Pharmaceuticals, Inc.
IRWD
$1.49
$0.042.76%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -2.97% | 26.07% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.97% | 26.07% | |||
| Cost of Revenue | -1.85% | 17.71% | |||
| Gross Profit | -3.50% | 30.46% | |||
| SG&A Expenses | -1.23% | -2.77% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -1.51% | 5.57% | |||
| Operating Income | -6.53% | 139.54% | |||
| Income Before Tax | -7.98% | 280.72% | |||
| Income Tax Expenses | -30.47% | 116.40% | |||
| Earnings from Continuing Operations | 523.95% | 79.34% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 523.95% | 79.34% | |||
| EBIT | -6.53% | 139.54% | |||
| EBITDA | -3.60% | 130.16% | |||
| EPS Basic | 522.22% | 79.55% | |||
| Normalized Basic EPS | -18.95% | 292.06% | |||
| EPS Diluted | 470.37% | 82.00% | |||
| Normalized Diluted EPS | -19.19% | 292.06% | |||
| Average Basic Shares Outstanding | 0.44% | 0.83% | |||
| Average Diluted Shares Outstanding | 0.77% | 0.83% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
